Increased Concentration of Receptor Activator of Nuclear Factor Kappa-B Ligand (RANKL) Predate Onset of Rheumatoid Arthritis

被引：0
|
作者：
Johansson, Linda [1 ]
Arlestig, Lisbeth [1 ]
Kokkonen, Heidi [1 ]
Rantapaa-Dahlqvist, Solbritt [2 ]
机构：
[1] Umea Univ, Publ Hlth & Clin Med Rheumatol, Umea, Sweden
[2] Umea Univ, Dept Publ Hlth & Clin Med Rheumatol, Umea, Sweden
来源：
ARTHRITIS & RHEUMATOLOGY | 2016年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
926
引用
收藏
页数：1
相关论文
共 50 条
  • [1] An increased concentration of receptor activator of nuclear factor kappa-B ligand pre-dates the onset of rheumatoid arthritis
    Johansson, Linda
    Arlestig, Lisbeth
    Kokkonen, Heidi
    Brink, Mikael
    Rantapaa-Dahlqvist, Solbritt
    RHEUMATOLOGY, 2017, 56 (12) : 2190 - 2196
  • [2] Receptor Activator of Nuclear Factor Kappa-B Ligand (RANKL) and Marginal Jawbone Loss Predates the Onset of Rheumatoid Arthritis
    Kindstedt, Elin
    Johansson, Linda
    Palmqvist, Py
    Holm, Cecilia Koskinen
    Kokkonen, Heidi
    Johansson, Ingegerd
    Lundberg, Pernilla
    Rantapaa-Dahlqvist, Solbritt
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [3] RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA-B LIGAND (RANKL) AND SCLEROSTIN ARE RELATED TO JOINT DESTRUCTION IN EARLY RHEUMATOID ARTHRITIS
    Rantapaa-Dahlqvist, S.
    Boman, A.
    Kokkonen, H.
    Berglin, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 679 - 680
  • [4] Receptor activator of nuclear factor kappa-B ligand (RANKL) serum levels are associated with progression to seropositive/negative rheumatoid arthritis
    Burska, A. N.
    El-Jawhari, J. J.
    Wu, J.
    Wakefield, R. J.
    Marzo-Ortega, H.
    Conaghan, P. G.
    Emery, P.
    Ponchel, F.
    Freeston, J. E.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2021, 39 (03) : 456 - 462
  • [5] Receptor activator of nuclear factor kappa-B ligand (RANKL) but not sclerostin or gene polymorphisms is related to joint destruction in early rheumatoid arthritis
    Boman, Antonia
    Kokkonen, Heidi
    Arlestig, Lisbeth
    Berglin, Ewa
    Rantapaa-Dahlqvist, Solbritt
    CLINICAL RHEUMATOLOGY, 2017, 36 (05) : 1005 - 1012
  • [6] Receptor activator of nuclear factor kappa-B ligand (RANKL) but not sclerostin or gene polymorphisms is related to joint destruction in early rheumatoid arthritis
    Antonia Boman
    Heidi Kokkonen
    Lisbeth Ärlestig
    Ewa Berglin
    Solbritt Rantapää-Dahlqvist
    Clinical Rheumatology, 2017, 36 : 1005 - 1012
  • [7] Receptor Activator of Nuclear Factor Kappa-B Ligand (RANKL) and Sclerostin Are Related to Joint Destruction in Early Rheumatoid Arthritis Unrelated to Polymorphisms of the Genes
    Boman, Antonia
    Kokkonen, Heidi
    Berglin, Ewa
    Arlestig, Lisbeth
    Rantapaa-Dahlqvist, Solbritt
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [8] The receptor activator of nuclear factor kappa-B ligand and the osteoprotegerin in synovial fluid at patients with psoriatic and rheumatoid arthritis
    Ciacli, C.
    ALLERGY, 2012, 67 : 288 - 288
  • [9] Marginal jawbone loss is associated with onset of rheumatoid arthritis and is related to plasma level of receptor activator of nuclear factor kappa-B ligand
    Johansson, L.
    Kindstedt, E.
    Palmqvist, P.
    Koskinen-Holm, C.
    Kokkonen, H.
    Johansson, I.
    Lundberg, P.
    Dahlqvist, S. Rantapaa
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2018, 47 : 22 - 22
  • [10] Methylation of receptor activator of nuclear factor kappa ligand (RANKL) gene in rheumatoid arthritis patients
    Ramzy, Manal
    Gharbia, Ola M.
    Seleem, Amal K.
    Mohamed, Karima
    Marzouk, Rehab E.
    EGYPTIAN RHEUMATOLOGIST, 2023, 45 (02): : 171 - 176
12345